Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies
Donato Amodio, Alessandra Ruggiero, Mayla Sgrulletti, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
Leanne P. M. van Leeuwen, Corine H. GeurtsvanKessel, Pauline M. Ellerbroek, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 6, pp. 1949-1957
Open Access | Times Cited: 62
The clinical impact of mRNA therapeutics in the treatment of cancers, infections, genetic disorders, and autoimmune diseases
Roham Deyhimfar, Mehrnaz Izady, Mohammadreza Shoghi, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26971-e26971
Open Access | Times Cited: 13
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis
Sara Sadeghi, Yasamin Kalantari, Sima Shokri, et al.
Journal of Clinical Virology (2022) Vol. 153, pp. 105196-105196
Open Access | Times Cited: 33
Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis
Juntao Yin, Yangyang Chen, Yang Li, et al.
International Journal of Infectious Diseases (2022) Vol. 124, pp. 212-223
Open Access | Times Cited: 33
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity
Stuart G. Tangye, Laurent Abel, Salah Al-Muhsen, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 4, pp. 818-831
Open Access | Times Cited: 29
SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity
Sophie Steiner, Tatjana Schwarz, Victor M. Corman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Immunizing the imperfect immune system
Jessica Durkee-Shock, Michael D. Keller
Annals of Allergy Asthma & Immunology (2022) Vol. 129, Iss. 5, pp. 562-571.e1
Open Access | Times Cited: 26
COVID-19 and Inborn Errors of Immunity
Ottavia M. Delmonte, Riccardo Castagnoli, Luigi D. Notarangelo
Physiology (2022) Vol. 37, Iss. 6, pp. 290-301
Open Access | Times Cited: 25
Towards personalized vaccines
Davide Montin, Veronica Santilli, Alessandra Beni, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency
Peter Bergman, David Wullimann, Yu Gao, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 4, pp. 716-727
Open Access | Times Cited: 20
Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections
Natalia Egri, Hugo Calderón, Robert Martinez, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
Leanne P. M. van Leeuwen, Marloes Grobben, Corine H. GeurtsvanKessel, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 6, pp. 1104-1117
Open Access | Times Cited: 12
Immunoglobulin therapy for immunodeficiency
Bridget E. Wilson, Catherine Freeman
Allergy and Asthma Proceedings (2024) Vol. 45, Iss. 5, pp. 364-370
Closed Access | Times Cited: 4
SARS-CoV-2 Infection and Response to COVID-19 Vaccination in Patients With Primary Immunodeficiencies
Robert Paris
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S24-S33
Open Access | Times Cited: 10
Shielding the immunocompromised: COVID-19 prevention strategies for patients with primary and secondary immunodeficiencies
G. Olivieri, Donato Amodio, Emma Concetta Manno, et al.
Vaccine (2025) Vol. 51, pp. 126853-126853
Open Access
Pre-vaccination immune markers predict response to BNT162b2 mRNA vaccine in vulnerable groups – The CONVERS project, report from a pediatric tertiary hospital
Nicola Cotugno, Marco Sanna, Donato Amodio, et al.
Vaccine (2025) Vol. 49, pp. 126778-126778
Open Access
Enhanced T-cell immunity and lower humoral responses following 5-dose SARS-CoV-2 vaccination in patients with inborn errors of immunity compared with healthy controls
Vitor Gabriel Lopes da Silva, G. Schmitz, Kathleen E. Sullivan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Analysis of humoral and cellular responses after vaccination against SARS-CoV-2 in patients with immune-mediated diseases
Thomas Escoda, Sylvie Jordana, L. Chiche, et al.
Diagnostic Microbiology and Infectious Disease (2025) Vol. 112, Iss. 3, pp. 116825-116825
Closed Access
Burden of COVID-19 in immunocompromised patients in Germany: a retrospective, observational Study on Health Insurance Data from 2021 to 2022
Julia Weinmann‐Menke, Clemens‐Martin Wendtner, Dennis Häckl, et al.
Infection (2025)
Open Access
T cells in SARS-CoV-2 infection and vaccination
Arthur P. Young
Therapeutic Advances in Vaccines and Immunotherapy (2022) Vol. 10
Open Access | Times Cited: 16
The (apparent) antibody paradox in COVID-19
Rohan Ameratunga, See‐Tarn Woon, Edward Lea, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 4, pp. 335-345
Open Access | Times Cited: 15
Perinatally Human Immunodeficiency Virus–Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity
Elena Morrocchi, Chiara Pighi, Giuseppe Rubens Pascucci, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_1, pp. S51-S60
Open Access | Times Cited: 15
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity
Daniel Leung, Xiaofeng Mu, Jaime S. Rosa Duque, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Long-Term Immunological Memory of SARS-CoV-2 Is Present in Patients with Primary Antibody Deficiencies for up to a Year after Vaccination
Zane Lucāne, Baiba Šlisere, Lota Ozola, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 354-354
Open Access | Times Cited: 8
Changes in the Adaptive Cellular Repertoire after Infection with Different SARS-CoV-2 VOCs in a Cohort of Vaccinated Healthcare Workers
Sara Caldrer, Silvia Accordini, Cristina Mazzi, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 230-230
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top